IFNA1 and viral infectious disease: Here, we show that PARP inhibitors specifically enhance the replication of MHV and decrease IFN production during macrodomain-mutant virus infection, further implicating the macrodomain in countering IFN-induced PARP-mediated antiviral ADP-ribosylation.